The global orphan drugs market presents many opportunities for new drug development, and advances in drug discovery capabilities coupled with regulatory and financial incentives are helping to generate rich pipelines of breakthrough treatments with true disease modifying properties, according to new analysis from Frost & Sullivan's Product and ... (more)
http://ift.tt/1gCPEAs
http://ift.tt/1gCPEAs
No comments:
Post a Comment